FDA label
What is sucralfate used for?
The FDA-approved uses of sucralfate, quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “Sucralfate tablets, USP are indicated in: Short-term treatment (up to 8 weeks) of active duodenal ulcer. While healing with sucralfate may occur during the first week or two, treatment should be continued for 4 to 8 weeks unless healing has been demonstrated by x-ray or endoscopic examination; Maintenance therapy for duodenal ulcer patients at reduced dosage after healing of acute ulcers.”
Run it in Rivvi
Which 2027 plans near you dropped or restricted sucralfate?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Sucralfate, tablet
Indications and Usage, quoted from the label by NCS HealthCare of KY, LLC dba Vangard Labs (ANDA070848). Cross-references to other label sections are left out.
Sucralfate tablets, USP are indicated in:
- Short-term treatment (up to 8 weeks) of active duodenal ulcer. While healing with sucralfate may occur during the first week or two, treatment should be continued for 4 to 8 weeks unless healing has been demonstrated by x-ray or endoscopic examination.
- Maintenance therapy for duodenal ulcer patients at reduced dosage after healing of acute ulcers.
Source: DailyMed label, set id d67dcaad-56c1-4e77-a0c8-655970808414, version 18, effective June 13, 2025. NDC 0615-4517, one of 37 listings for this product.
Sucralfate, suspension
Indications and Usage, quoted from the label by PAI Holdings, LLC dba PAI Pharma (ANDA211884). Cross-references to other label sections are left out.
Sucralfate Oral Suspension is indicated in the short-term (up to 8 weeks) treatment of active duodenal ulcer.
Source: DailyMed label, set id 113a068a-2ce9-421c-8b89-87ce30e19225, version 6, effective March 11, 2026. NDC 0121-0974, one of 22 listings for this product.
Questions
What is sucralfate used for?
The FDA label says: “Sucralfate tablets, USP are indicated in: Short-term treatment (up to 8 weeks) of active duodenal ulcer. While healing with sucralfate may occur during the first week or two, treatment should be continued for 4 to 8 weeks unless healing has been demonstrated by x-ray or endoscopic examination; Maintenance therapy for duodenal ulcer patients at reduced dosage after healing of acute ulcers.”
What drug class is sucralfate?
FDA lists sucralfate in the Aluminum Complex established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.